We use cookies in our website, so that we can offer you an amazing experience. Would you like to know more about our Privacy Policy ?
OK, got it!
Oncopharmpod

Oncopharmpod

It's All Immunotherapy Nowadays

Informações:

Add to list
Listen
preview
Listen

Synopsis

Durvalumab's FDA-approval for NSCLC and the supporting PACIFIC study are discussed, then the ASCO Immunotherapy Toxicity Management Guidelines (7:45) are reviewed. Also, a plug for patient support groups.

Show more
Join Now

Join Now

  • Unlimited access to all content on the platform.
  • More than 30 thousand titles, including audiobooks, ebooks, podcasts, series and documentaries.
  • Narration of audiobooks by professionals, including actors, announcers and even the authors themselves.
Try it Now Firm without compromise. Cancel whenever you want.

Share